Microdosing aims to extend the lifespan of the GLP-1 compounding market Marketing claims about GLP-1s in small doses aren’t backed by robust clinical evidence

https://www.statnews.com/2025/11/04/microdosing-glp-1-drugs-no-clinical-evidence-effective/ A miracle pill for Parkinson’s is 50 years old. Why can’t most of the world get it? Parkinson’s cases have doubled in the past 25 years, increasing more quickly than any other neurodegenerative disease https://www.statnews.com/2025/11/04/parkinsons-disease-treatment-greater-levodopa-access-how-to/ Jennifer Doudna spinoff aims to turn patients’ immune cells into CAR-T fighters with single shot Azalea Therapeutics raises $82 million, pursuing in vivo CAR-T for cancer and autoimmune disease https://www.statnews.com/2025/11/04/jennifer-doudna-biotech-azalea-therapeutics-raises-82-million/ UnitedHealth pays its own physician groups 17% more than outside ones, study shows Finding suggests UnitedHealth may be skirting a rule to curb insurers’ profits https://www.statnews.com/2025/11/03/unitedhealth-pays-its-optum-physicians-17-percent-more/